Accelerating Drug Development and Approval: The Use of Pharmacodynamics
4th ISAP / ICAAC symposium
held during the 41th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), Chicago, Ill., December 16th-19th, 2001.

Viewing Chicago fast growth ...

  • Use of Pharmacodynamic Principles in the Drug Discovery Process
    Michael N. Dudley, Microcide Pharmaceuticals, Inc., Mountain View, CA
  • Phase 2/3 Drug Evaluation of Antivirals: Efficacy and Development of ResistanceGeorge 
    L. Drusano, Albany Medical College, Albany, NY
  • Are Pharmacodynamics an Alternative for Human Trials in the Evaluation of Antifungals ?
    David R. Andes, University  of Wisconsin, Madison, WI
  • Use of in vitro Pharmacokinetic Models in Defining Dosing Regimens
    Alasdair MacGowan, Southmead Hospital, Bristol, Avon, United Kingdom
  • Limitations of Animal Models for Predicting Efficacy and Defining Dose
    James E. Leggett, Providence Portland Medical Center, Portland, OR

Goals and format

The symposium has presented a "state of the art" of pharmacodynamic/pharmacokinetic research

Timing: each speaker was allotted 20 minutes for a presentation, leaving 10 minutes for questions and answers.

Intended audience:   Scientists, physicians, and clinical pharmacists involved in drug development in Industry, Academic Institutions, Hospitals and Regulatory Bodies.

Level: intermediate to advanced

Accreditation: The symposium was eligible for Continuing education / Accreditation


Back to ISAP home page

Credits
Back to ISAP home page